Skip to Content

Ipreziv

Active Substance: azilsartan medoxomil
Common Name: azilsartan medoxomil
ATC Code: C09CA09
Marketing Authorisation Holder: Takeda Pharma A/S
Active Substance: azilsartan medoxomil
Status: Withdrawn
Authorisation Date: 2011-12-07
Therapeutic Area: Hypertension
Pharmacotherapeutic Group: Agents acting on the renin-angiotensin system

Therapeutic Indication

Ipreziv is indicated for the treatment of essential hypertension in adults.

The marketing authorisation for Ipreziv has been withdrawn at the request of the marketing authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide